Molsid is an innovative biomed company based in Lyon, France. We develop SmartID, a new generation of molecular probes. They respond to the presence of specific enzymatic activity by acting as substrates that generate an intense fluorescence with innovative signal retention. SmartID allows for the monitoring of many cellular processes, and through this also to detect and identify bacteria.
Our SmartID probes include diagnostic solutions for antimicrobial resistance (AMR) intended for clinical applications in emergency situations. We also develop diagnostic tests for many different pathologies where abnormal enzymatic activities are relevant signatures of the disease.
Molsid can provide custom-made molecular probes for targeting enzyme biomarkers, as a service provider or through R&D collaboration with biotech and medtech companies.
We would be delighted to meet you at MEDICA.